Norges Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-114,194
| Closed | -$34.6M | – | 185 |
|
|
2025
Q4 | $34.6M | Buy |
+114,194
| New | +$35.6M | ﹤0.01% | 1126 |
|
|
2025
Q3 | – | Sell |
-128,408
| Closed | -$31M | – | 211 |
|
|
2025
Q2 | $31M | Sell |
128,408
-28,306
| -18% | -$6.69M | ﹤0.01% | 1114 |
|
|
2025
Q1 | $38.2M | Buy |
156,714
+29,948
| +24% | +$9.01M | 0.01% | 1039 |
|
|
2024
Q4 | $41.6M | Sell |
126,766
-67,756
| -35% | -$23M | 0.01% | 1030 |
|
|
2024
Q3 | $65.1M | Sell |
194,522
-32,045
| -14% | -$10.2M | 0.01% | 857 |
|
|
2024
Q2 | $61.9M | Sell |
226,567
-8,239
| -4% | -$2.4M | 0.01% | 822 |
|
|
2024
Q1 | $81.2M | Buy |
234,806
+8,283
| +4% | +$2.72M | 0.01% | 719 |
|
|
2023
Q4 | $73.1M | Sell |
226,523
-735
| -0.3% | -$230K | 0.01% | 732 |
|
|
2023
Q3 | $81.5M | Hold |
227,258
| – | – | 0.02% | 636 |
|
|
2023
Q2 | $86.2M | Buy |
227,258
+928
| +0.4% | +$378K | 0.02% | 618 |
|
|
2023
Q1 | $108M | Buy |
226,330
+8,863
| +4% | +$4.15M | 0.02% | 529 |
|
|
2022
Q4 | $91.4M | Buy |
217,467
+15,502
| +8% | +$6.26M | 0.02% | 569 |
|
|
2022
Q3 | $84.2M | Buy |
201,965
+4,222
| +2% | +$2.1M | 0.02% | 572 |
|
|
2022
Q2 | $97.9M | Sell |
197,743
-11,554
| -6% | -$6.02M | 0.03% | 530 |
|
|
2022
Q1 | $118M | Sell |
209,297
-3,989
| -2% | -$2.4M | 0.03% | 531 |
|
|
2021
Q4 | $161M | Buy |
213,286
+6,426
| +3% | +$4.81M | 0.03% | 468 |
|
|
2021
Q3 | $154M | Sell |
206,860
-1,571
| -0.8% | -$1.18M | 0.03% | 484 |
|
|
2021
Q2 | $134M | Sell |
208,431
-2,066
| -1% | -$1.26M | 0.03% | 532 |
|
|
2021
Q1 | $120M | Buy |
210,497
+5,315
| +3% | +$3.15M | 0.03% | 572 |
|
|
2020
Q4 | $120M | Sell |
205,182
-16,832
| -8% | -$9.59M | 0.03% | 535 |
|
|
2020
Q3 | $114M | Buy |
222,014
+6,530
| +3% | +$3.31M | 0.03% | 491 |
|
|
2020
Q2 | $97.3M | Buy |
215,484
+6,555
| +3% | +$2.89M | 0.03% | 508 |
|
|
2020
Q1 | $73.2M | Sell |
208,929
-2,342
| -1% | -$861K | 0.03% | 543 |
|
|
2019
Q4 | $78.2M | Buy |
211,271
+1,775
| +0.8% | +$626K | 0.02% | 661 |
|
|
2019
Q3 | $69.7M | Buy |
209,496
+1,558
| +0.7% | +$508K | 0.02% | 678 |
|
|
2019
Q2 | $65M | Hold |
207,938
| – | – | 0.02% | 722 |
|
|
2019
Q1 | $63.6M | Buy |
207,938
+8,442
| +4% | +$2.28M | 0.02% | 706 |
|
|
2018
Q4 | $46.3M | Buy |
199,496
+7,363
| +4% | +$1.98M | 0.02% | 801 |
|
|
2018
Q3 | $60.1M | Buy |
192,133
+14,123
| +8% | +$4.38M | 0.02% | 733 |
|
|
2018
Q2 | $51.4M | Sell |
178,010
-1,688
| -0.9% | -$466K | 0.02% | 813 |
|
|
2018
Q1 | $44.9M | Buy |
179,698
+5,426
| +3% | +$1.38M | 0.02% | 855 |
|
|
2017
Q4 | $41.6M | Hold |
174,272
| – | – | 0.01% | 921 |
|
|
2017
Q3 | $38.7M | Sell |
174,272
-8,709
| -5% | -$1.96M | 0.01% | 950 |
|
|
2017
Q2 | $41.4M | Buy |
182,981
+22,309
| +14% | +$4.86M | 0.02% | 872 |
|
|
2017
Q1 | $32M | Buy |
160,672
+16,834
| +12% | +$3.24M | 0.01% | 1031 |
|
|
2016
Q4 | $26.2M | Sell |
143,838
-24,824
| -15% | -$4.23M | 0.01% | 1125 |
|
|
2016
Q3 | $26.4M | Hold |
168,662
| – | – | 0.01% | 1029 |
|
|
2016
Q2 | $24.1M | Hold |
168,662
| – | – | 0.01% | 1080 |
|
|
2016
Q1 | $23.1M | Hold |
168,662
| – | – | 0.01% | 1077 |
|
|
2015
Q4 | $23.4M | Buy |
168,662
+700
| +0.4% | +$97K | 0.01% | 1070 |
|
|
2015
Q3 | $22.6M | Hold |
167,962
| – | – | 0.01% | 1056 |
|
|
2015
Q2 | $25.3M | Hold |
167,962
| – | – | 0.01% | 1048 |
|
|
2015
Q1 | $22.7M | Buy |
167,962
+13,550
| +9% | +$1.68M | 0.01% | 1128 |
|
|
2014
Q4 | $18.6M | Hold |
154,412
| – | – | 0.01% | 1258 |
|
|
2014
Q3 | $17.5M | Sell |
154,412
-154,412
| -50% | -$18.3M | 0.01% | 1224 |
|
|
2014
Q2 | $37M | Buy |
308,824
+154,412
| +100% | +$18.9M | 0.01% | 1212 |
|
|
2014
Q1 | $19.8M | Hold |
154,412
| – | – | 0.01% | 1139 |
|
|
2013
Q4 | $19.1M | Hold |
154,412
| – | – | 0.01% | 1145 |
|
|
2013
Q3 | $18.2M | Buy |
154,412
+50,719
| +49% | +$5.98M | 0.01% | 1145 |
|
|
2013
Q2 | $11.6M | Buy |
+103,693
| New | +$12.2M | 0.01% | 1378 |
|
Other funds holding BIO
VCM
VPM
AI
